Spirulina supplementation and circuit resistance training (CRT) reduce serum asprosin and appetite and improve energy balance in men with obesity and overweight
Hormones · 2025
DOI: 10.1007/s42000-024-00595-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Hormones, 2025. Verfasst von Nakhaei Hossein und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. Hauptthemen laut MEDLINE: Spirulina, Obesity, Energy Metabolism, Dietary Supplements. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Zahedan University of Medical Sciences.
Abstract (Originalsprache)
PURPOSE: The present study aimed to investigate the effects of 8 weeks spirulina supplementation and circuit resistance training (CRT) on asprosin, appetite, and energy balance in men with obesity and overweight. METHODS: The study comprised a single-blind randomized controlled trial. Sixty men with obesity and overweight (BMI > 25) were selected and randomly divided into four equal groups (n = 15 each) of training plus spirulina, training plus placebo, spirulina, and placebo. The participants of the training groups performed 12 movements with 40-90% maximal repetition (three sessions per week) and the supplemental groups consumed 1000 mg of spirulina per day for 8 weeks. Asprosin, appetite using visual analog scales, calorie intake, energy expenditure, and body composition were measured before and after the intervention. To analyze the data, the paired sample t-test, analysis of covariance, Bonferroni post-hoc, and Pearson correlation tests were employed using SPSS (version 20) at a significance level of p < 0.05. RESULTS: After the intervention, asprosin level (P = 0.015, P = 0.015, and P = 0.020, respectively), weight (P < 0.001, P < 0.001, and P < 0.001, respectively), calorie intake (P = 0.015, P = 0.011, and P = 0.004, respectively), and hunger (P = 0.011, P = 0.015, and P = 0.015, respectively) declined in the training plus spirulina, training plus placebo, and spirulina groups (p < 0.05). In addition, energy expenditure (P = 0.012 and P = 0.015, respectively) and fullness (P = 0.015 and P = 0.011, respectively) increased in the training plus spirulina and training plus placebo groups. The mean changes of the research indicators in the training plus spirulina group were significantly more than those of the other groups (p < 0.001). CONCLUSION: It was shown that 8 weeks of CRT and spirulina supplementation decreases the level of asprosin and improves appetite and energy balance in men with obesity and overweight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
- Faculty of Sport Sciences, University of Birjand, Birjand, Iran.
- University of Birjand, Birjand, Iran.
- Department of Sport Sciences, Faculty of Literature and Humanities, University of Zabol, Zabol, Iran. elhamghasemi@uoz.ac.ir.
Förderung
- Zahedan University of Medical Sciences
Zitieren
APA
Hossein, N., Mehdi, M., Karim, D., Mahdi, M., & Ghasemi, E. (2025). Spirulina supplementation and circuit resistance training (CRT) reduce serum asprosin and appetite and improve energy balance in men with obesity and overweight. Hormones. https://doi.org/10.1007/s42000-024-00595-2
Vancouver
Hossein N, Mehdi M, Karim D, Mahdi M, Ghasemi E. Spirulina supplementation and circuit resistance training (CRT) reduce serum asprosin and appetite and improve energy balance in men with obesity and overweight. Hormones. 2025. doi:10.1007/s42000-024-00595-2
BibTeX
@article{Hossein2025,
author = {Hossein, Nakhaei and Mehdi, Mogharnasi and Karim, Dehghani and Mahdi, Mohammadi and Ghasemi, Elham},
title = {Spirulina supplementation and circuit resistance training (CRT) reduce serum asprosin and appetite and improve energy balance in men with obesity and overweight},
journal = {Hormones},
year = {2025},
doi = {10.1007/s42000-024-00595-2}
}
EUVIMED